Economic Impact of Antidiabetic Medications and Glycemic Control on Managed Care Organizations: A Review of the Literature

OBJECTIVES: To review the recent literature (January 2000-November 2005) regarding the impact of antidiabetic medications and glycemic control on the overall costs of care for patients with diabetes in U.S. managed care organizations (MCOs). SUMMARY: The pharmacy component accounts for typically 20%...

Descripción completa

Detalles Bibliográficos
Autores principales: Stephens, Jennifer M., Botteman, Marc F., Hay, Joel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437381/
https://www.ncbi.nlm.nih.gov/pubmed/16515371
http://dx.doi.org/10.18553/jmcp.2006.12.2.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437381/
https://www.ncbi.nlm.nih.gov/pubmed/16515371
http://dx.doi.org/10.18553/jmcp.2006.12.2.130

Ejemplares similares